Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123505002 | 12350500 | 2 | F | 201504 | 20160629 | 20160510 | 20160707 | EXP | PHHY2016FR063630 | NOVARTIS | 62.26 | YR | F | Y | 0.00000 | 20160707 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123505002 | 12350500 | 1 | PS | FEMARA | LETROZOLE | 1 | Unknown | 2.5 MG, QD (1 DF DAILY) | 20726 | 2.5 | MG | TABLET | QD | ||||||
| 123505002 | 12350500 | 2 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 123505002 | 12350500 | 3 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123505002 | 12350500 | 1 | Breast cancer |
| 123505002 | 12350500 | 2 | Product used for unknown indication |
| 123505002 | 12350500 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123505002 | 12350500 | OT |
| 123505002 | 12350500 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123505002 | 12350500 | Arthralgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123505002 | 12350500 | 1 | 201406 | 0 |